Supernus Pharm (SUPN) Posts Q3 Loss of 55c/Share

Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.55), $0.07 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Columbia Financial, Inc. Announces Preliminary Subscription Offering Results and Increase in Maximum Purchase Limits
• Cerebras Q1 EPS miss sends shares down 9% after-hours